| 1 | [SID103735736] | Active | IC50 | 0.001 | Inhibition of human microsomal 11beta-HSD2 expressed in HEK293 cells assessed as conversion of [3H]cortisone to [3H]cortisol by scintillation proximity assay [AID433139, Type: Literature] | Corticosteroid 11-beta-dehydrogenase isozyme 2 [gi:30316367] |   View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Active | | IC50 | 0.001 [uM] | | BioAssay | Inhibition of human microsomal 11beta-HSD2 expressed in HEK293 cells assessed as conversion of [3H]cortisone to [3H]cortisol by scintillation proximity assay | | AID | 433139 | | BioAssay type | Literature | | Target | Corticosteroid 11-beta-dehydrogenase isozyme 2 [gi:30316367] | | PubMed | 19564108 | | Data Table |  |
|
| 2 | [SID103735736] | Active | EC50 | 0.001 | Inhibition of human 11beta-HSD2 expressed in HEK293 cells assessed as [3H]cortisol production after 60 mins by SPA [AID657950, Type: Literature] | |   View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Active | | EC50 | 0.001 [uM] | | BioAssay | Inhibition of human 11beta-HSD2 expressed in HEK293 cells assessed as [3H]cortisol production after 60 mins by SPA | | AID | 657950 | | BioAssay type | Literature | | Target | | | PubMed | 22440625 | | Data Table |  |
|
| 3 | [SID103735736] | Active | EC50 | 0.008 | Inhibition of mouse 11beta-HSD1 expressed in HEK293 cells assessed as [3H]cortisol production after 60 mins by SPA [AID657949, Type: Literature] | |   View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Active | | EC50 | 0.008 [uM] | | BioAssay | Inhibition of mouse 11beta-HSD1 expressed in HEK293 cells assessed as [3H]cortisol production after 60 mins by SPA | | AID | 657949 | | BioAssay type | Literature | | Target | | | PubMed | 22440625 | | Data Table |  |
|
| 4 | [SID103735736] | Active | IC50 | 0.008 | Inhibition of mouse microsomal 11beta-HSD1 expressed in HEK293 cells assessed as conversion of [3H]cortisone to [3H]cortisol by scintillation proximity assay [AID433138, Type: Literature] | Corticosteroid 11-beta-dehydrogenase isozyme 1 [gi:1706408] |   View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Active | | IC50 | 0.008 [uM] | | BioAssay | Inhibition of mouse microsomal 11beta-HSD1 expressed in HEK293 cells assessed as conversion of [3H]cortisone to [3H]cortisol by scintillation proximity assay | | AID | 433138 | | BioAssay type | Literature | | Target | Corticosteroid 11-beta-dehydrogenase isozyme 1 [gi:1706408] | | PubMed | 19564108 | | Data Table |  |
|
| 5 | [SID103735736] | Active | EC50 | 0.01 | Inhibition of human 11beta-HSD1 expressed in HEK293 cells assessed as [3H]cortisol production after 60 mins by SPA [AID657948, Type: Literature] | |   View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Active | | EC50 | 0.01 [uM] | | BioAssay | Inhibition of human 11beta-HSD1 expressed in HEK293 cells assessed as [3H]cortisol production after 60 mins by SPA | | AID | 657948 | | BioAssay type | Literature | | Target | | | PubMed | 22440625 | | Data Table |  |
|
| 6 | [SID103735736] | Active | IC50 | 0.01 | Inhibition of human microsomal 11beta-HSD1 expressed in HEK293 cells assessed as conversion of [3H]cortisone to [3H]cortisol by scintillation proximity assay [AID433137, Type: Literature] | Corticosteroid 11-beta-dehydrogenase isozyme 1 [gi:118569] |   View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Active | | IC50 | 0.01 [uM] | | BioAssay | Inhibition of human microsomal 11beta-HSD1 expressed in HEK293 cells assessed as conversion of [3H]cortisone to [3H]cortisol by scintillation proximity assay | | AID | 433137 | | BioAssay type | Literature | | Target | Corticosteroid 11-beta-dehydrogenase isozyme 1 [gi:118569] | | PubMed | 19564108 | | Data Table |  |
|
| 7 | [SID103735736] | Active | IC50 | 0.01 | Inhibition of human microsomal 11beta-HSD1 expressed in HEK293 cells assessed as conversion of [3H]cortisone to [3H]cortisol by scintillation proximity assay [AID433137, Type: Literature] | Corticosteroid 11-beta-dehydrogenase isozyme 1 [gi:118569] |   View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Active | | IC50 | 0.01 [uM] | | BioAssay | Inhibition of human microsomal 11beta-HSD1 expressed in HEK293 cells assessed as conversion of [3H]cortisone to [3H]cortisol by scintillation proximity assay | | AID | 433137 | | BioAssay type | Literature | | Target | Corticosteroid 11-beta-dehydrogenase isozyme 1 [gi:118569] | | PubMed | 19564108 | | Data Table |  |
|
| 8 | [SID103735736] | Active | IC50 | 0.015 | Inhibition of mouse liver microsome 11betaHSD1 expressed in HEK293 cells assessed as conversion of [3H]cortisone into [3H]cortisol by scintillation proximity assay [AID431046, Type: Literature] | Corticosteroid 11-beta-dehydrogenase isozyme 1 [gi:1706408] |   View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Active | | IC50 | 0.015 [uM] | | BioAssay | Inhibition of mouse liver microsome 11betaHSD1 expressed in HEK293 cells assessed as conversion of [3H]cortisone into [3H]cortisol by scintillation proximity assay | | AID | 431046 | | BioAssay type | Literature | | Target | Corticosteroid 11-beta-dehydrogenase isozyme 1 [gi:1706408] | | PubMed | 19574056 | | Data Table |  |
|
| 9 | [SID103735736] | Unspecified | Ki | 0.84 | TP_TRANSPORTER: inhibition of DNP-SG uptake in bile canalicular membrane vesicles from SD rat [AID681175, Type: other] | |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Unspecified | | Ki | 0.84 [uM] | | BioAssay | TP_TRANSPORTER: inhibition of DNP-SG uptake in bile canalicular membrane vesicles from SD rat | | AID | 681175 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 10 | [SID103735736] | Unspecified | Ki | 1.91 | TP_TRANSPORTER: inhibition of SN-38 uptake in bile canalicular membrane vesicles from SD rat [AID679806, Type: other] | |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Unspecified | | Ki | 1.91 [uM] | | BioAssay | TP_TRANSPORTER: inhibition of SN-38 uptake in bile canalicular membrane vesicles from SD rat | | AID | 679806 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 11 | [SID103735736] | Unspecified | Ki | 6.1 | TP_TRANSPORTER: inhibition of E1S uptake in Xenopus laevis oocytes [AID681650, Type: other] | |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Unspecified | | Ki | 6.1 [uM] | | BioAssay | TP_TRANSPORTER: inhibition of E1S uptake in Xenopus laevis oocytes | | AID | 681650 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 12 | [SID103735736] | Unspecified | Ki | 12.5 | TP_TRANSPORTER: inhibition of BSP uptake in Xenopus laevis oocytes [AID680384, Type: other] | |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Unspecified | | Ki | 12.5 [uM] | | BioAssay | TP_TRANSPORTER: inhibition of BSP uptake in Xenopus laevis oocytes | | AID | 680384 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 13 | [SID103735736] | Unspecified | Ki | 15.9 | TP_TRANSPORTER: inhibition of E1S uptake in Xenopus laevis oocytes [AID680745, Type: other] | |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Unspecified | | Ki | 15.9 [uM] | | BioAssay | TP_TRANSPORTER: inhibition of E1S uptake in Xenopus laevis oocytes | | AID | 680745 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 14 | [SID103735736] | Unspecified | IC50 | 82.4 | Hepatoprotective activity in mouse hepatocytes assessed inhibition of D-galactosamine/TNFalpha-induced cell death dosed administered before 30 mins of TNFalpha challenge measured after 18 hrs [AID359488, Type: Literature] | |   View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Unspecified | | IC50 | 82.4 [uM] | | BioAssay | Hepatoprotective activity in mouse hepatocytes assessed inhibition of D-galactosamine/TNFalpha-induced cell death dosed administered before 30 mins of TNFalpha challenge measured after 18 hrs | | AID | 359488 | | BioAssay type | Literature | | Target | | | PubMed | 11325227 | | Data Table |  |
|
| 15 | [SID103735736] | Unspecified | IC50 | 100 | Inhibition of human recombinant PTP1B [AID265377, Type: Literature] | Tyrosine-protein phosphatase non-receptor type 1 [gi:131467] |   View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Unspecified | | IC50 | 100 [uM] | | BioAssay | Inhibition of human recombinant PTP1B | | AID | 265377 | | BioAssay type | Literature | | Target | Tyrosine-protein phosphatase non-receptor type 1 [gi:131467] | | PubMed | 16580200 | | Data Table |  |
|
| 16 | [SID103735736] | Unspecified | IC50 | 200 | Hepatoprotective activity against D-galactosamine/TNFalpha-induced cell death in primary cultured mouse hepatocytes treated for 30 mins before TNFalpha challenge measured after 18 hrs by MTT assay [AID359156, Type: Literature] | |   View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Unspecified | | IC50 | 200 [uM] | | BioAssay | Hepatoprotective activity against D-galactosamine/TNFalpha-induced cell death in primary cultured mouse hepatocytes treated for 30 mins before TNFalpha challenge measured after 18 hrs by MTT assay | | AID | 359156 | | BioAssay type | Literature | | Target | | | PubMed | 11277757 | | Data Table |  |
|
| 17 | [SID103735736] | Unspecified | IC50 | 381 | Inhibition of TPA-induced EBV-early antigen activation in human Raji cells after 48hrs by indirect immunofluorescence technique [AID348191, Type: Literature] | |   View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Unspecified | | IC50 | 381 [uM] | | BioAssay | Inhibition of TPA-induced EBV-early antigen activation in human Raji cells after 48hrs by indirect immunofluorescence technique | | AID | 348191 | | BioAssay type | Literature | | Target | | | PubMed | 19131254 | | Data Table |  |
|
| 18 | [SID103735736] | Unspecified | IC50 | 822 | Inhibition of rabbit muscle glycogen phosphorylase A assessed as phosphate release from glucose-1-phosphate [AID404873, Type: Literature] | Glycogen phosphorylase, muscle form [gi:6093713] |   View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Unspecified | | IC50 | 822 [uM] | | BioAssay | Inhibition of rabbit muscle glycogen phosphorylase A assessed as phosphate release from glucose-1-phosphate | | AID | 404873 | | BioAssay type | Literature | | Target | Glycogen phosphorylase, muscle form [gi:6093713] | | PubMed | 18517260 | | Data Table |  |
|
| 19 | [SID103735736] | Unspecified | IC50 | | DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid) [AID625146, Type: other] | Arachidonate 15-lipoxygenase [gi:126397] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid) | | AID | 625146 | | BioAssay type | other | | Target | Arachidonate 15-lipoxygenase [gi:126397] | | PubMed | | | Data Table |  |
|
| 20 | [SID103735736] | Unspecified | IC50 | | DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG) [AID625173, Type: other] | Angiotensin-converting enzyme [gi:2822103] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG) | | AID | 625173 | | BioAssay type | other | | Target | Angiotensin-converting enzyme [gi:2822103] | | PubMed | | | Data Table |  |
|
| 21 | [SID103735736] | Unspecified | IC50 | | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808) [AID625220, Type: other] | 5-hydroxytryptamine receptor 4 [gi:6224984] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808) | | AID | 625220 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 4 [gi:6224984] | | PubMed | | | Data Table |  |
|
| 22 | [SID103735736] | Unspecified | | | TP_TRANSPORTER: inhibition of E1S uptake (E1S: 0.05 uM, GL: 100 uM) in Xenopus laevis oocytes [AID680621, Type: other] | |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Unspecified | | BioAssay | TP_TRANSPORTER: inhibition of E1S uptake (E1S: 0.05 uM, GL: 100 uM) in Xenopus laevis oocytes | | AID | 680621 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 23 | [SID103735736] | Unspecified | | | TP_TRANSPORTER: inhibition of E1S uptake (E1S: 0.05 uM, GL: 100 uM) by Glycyrrhizic acid at a concentration of 100 u M in Xenopus laevis oocytes [AID680021, Type: other] | |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Unspecified | | BioAssay | TP_TRANSPORTER: inhibition of E1S uptake (E1S: 0.05 uM, GL: 100 uM) by Glycyrrhizic acid at a concentration of 100 u M in Xenopus laevis oocytes | | AID | 680021 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 24 | [SID103735736] | Unspecified | | | TP_TRANSPORTER: inhibition of E1S uptake (E1S: 0.05 uM, GL: 100 uM) in Xenopus laevis oocytes [AID680383, Type: other] | |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Unspecified | | BioAssay | TP_TRANSPORTER: inhibition of E1S uptake (E1S: 0.05 uM, GL: 100 uM) in Xenopus laevis oocytes | | AID | 680383 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 25 | [SID103735736] | Unspecified | | | Inhibition of human recombinant 11beta-HSD2 expressed in HEK293 cells assessed as oxidation of [1,2,6,7-3H]cortisol to cortisone at 1 uM after 10 mins by scintillation counting [AID456097, Type: Literature] | Corticosteroid 11-beta-dehydrogenase isozyme 2 [gi:30316367] |   View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Unspecified | | BioAssay | Inhibition of human recombinant 11beta-HSD2 expressed in HEK293 cells assessed as oxidation of [1,2,6,7-3H]cortisol to cortisone at 1 uM after 10 mins by scintillation counting | | AID | 456097 | | BioAssay type | Literature | | Target | Corticosteroid 11-beta-dehydrogenase isozyme 2 [gi:30316367] | | PubMed | 19914836 | | Data Table |  |
|
| 26 | [SID103735736] | Unspecified | | | Hepatoprotective activity in mouse hepatocytes assessed protection against D-galactosamine/TNFalpha-induced cell death at 200 uM administered before 30 mins of TNFalpha challenge measured after 18 hrs [AID359484, Type: Literature] | |   View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Unspecified | | BioAssay | Hepatoprotective activity in mouse hepatocytes assessed protection against D-galactosamine/TNFalpha-induced cell death at 200 uM administered before 30 mins of TNFalpha challenge measured after 18 hrs | | AID | 359484 | | BioAssay type | Literature | | Target | | | PubMed | 11325227 | | Data Table |  |
|
| 27 | [SID103735736] | Unspecified | | | Hepatoprotective activity in mouse hepatocytes assessed protection against D-galactosamine/TNFalpha-induced cell death at 50 uM administered before 30 mins of TNFalpha challenge measured after 18 hrs [AID359487, Type: Literature] | |   View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Unspecified | | BioAssay | Hepatoprotective activity in mouse hepatocytes assessed protection against D-galactosamine/TNFalpha-induced cell death at 50 uM administered before 30 mins of TNFalpha challenge measured after 18 hrs | | AID | 359487 | | BioAssay type | Literature | | Target | | | PubMed | 11325227 | | Data Table |  |
|
| 28 | [SID103735736] | Unspecified | | | TP_TRANSPORTER: biliary excretion in SD rat [AID679047, Type: other] | |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Unspecified | | BioAssay | TP_TRANSPORTER: biliary excretion in SD rat | | AID | 679047 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 29 | [SID103735736] | Unspecified | | | TP_TRANSPORTER: biliary excretion in EHBR rat [AID679048, Type: other] | |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Unspecified | | BioAssay | TP_TRANSPORTER: biliary excretion in EHBR rat | | AID | 679048 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 30 | [SID103735736] | Unspecified | | | TP_TRANSPORTER: inhibition of E1S uptake (E1S: 0.05 uM, GL: 100 uM) of Glycyrrhizic acid at a concentration of 100 u M in Xenopus laevis oocytes [AID679438, Type: other] | |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Unspecified | | BioAssay | TP_TRANSPORTER: inhibition of E1S uptake (E1S: 0.05 uM, GL: 100 uM) of Glycyrrhizic acid at a concentration of 100 u M in Xenopus laevis oocytes | | AID | 679438 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 31 | [SID103735736] | Unspecified | | | DRUGMATRIX: Nitric Oxide Synthase, Inducible (iNOS) enzyme inhibition (substrate: L-Arginine) [AID625160, Type: other] | Nitric oxide synthase, inducible [gi:266649] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Unspecified | | BioAssay | DRUGMATRIX: Nitric Oxide Synthase, Inducible (iNOS) enzyme inhibition (substrate: L-Arginine) | | AID | 625160 | | BioAssay type | other | | Target | Nitric oxide synthase, inducible [gi:266649] | | PubMed | | | Data Table |  |
|
| 32 | [SID103735736] | Unspecified | IC50 | | DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) [AID625199, Type: other] | Alpha-1B adrenergic receptor [gi:543734] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) | | AID | 625199 | | BioAssay type | other | | Target | Alpha-1B adrenergic receptor [gi:543734] | | PubMed | | | Data Table |  |
|
| 33 | [SID103735736] | Unspecified | IC50 | | DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) [AID625199, Type: other] | Alpha-1B adrenergic receptor [gi:543734] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) | | AID | 625199 | | BioAssay type | other | | Target | Alpha-1B adrenergic receptor [gi:543734] | | PubMed | | | Data Table |  |
|
| 34 | [SID103735736] | Unspecified | IC50 | | DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde) [AID625208, Type: other] | Aldose reductase [gi:1168407] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde) | | AID | 625208 | | BioAssay type | other | | Target | Aldose reductase [gi:1168407] | | PubMed | | | Data Table |  |
|
| 35 | [SID103735736] | Unspecified | IC50 | | DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone) [AID625228, Type: other] | Androgen receptor [gi:113832] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone) | | AID | 625228 | | BioAssay type | other | | Target | Androgen receptor [gi:113832] | | PubMed | | | Data Table |  |
|
| 36 | [SID103735736] | Unspecified | IC50 | | DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone) [AID625228, Type: other] | Androgen receptor [gi:113832] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone) | | AID | 625228 | | BioAssay type | other | | Target | Androgen receptor [gi:113832] | | PubMed | | | Data Table |  |
|
| 37 | [SID103735736] | Unspecified | IC50 | | DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine) [AID625159, Type: other] | Nitric oxide synthase, brain [gi:266646] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine) | | AID | 625159 | | BioAssay type | other | | Target | Nitric oxide synthase, brain [gi:266646] | | PubMed | | | Data Table |  |
|
| 38 | [SID103735736] | Unspecified | IC50 | | DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin) [AID625273, Type: other] | Insulin receptor [gi:124531] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin) | | AID | 625273 | | BioAssay type | other | | Target | Insulin receptor [gi:124531] | | PubMed | | | Data Table |  |
|
| 39 | [SID103735736] | Unspecified | IC50 | | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol) [AID625191, Type: other] | 5-hydroxytryptamine receptor 1B [gi:112815] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol) | | AID | 625191 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 1B [gi:112815] | | PubMed | | | Data Table |  |
|
| 40 | [SID103735736] | Unspecified | IC50 | | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol) [AID625191, Type: other] | 5-hydroxytryptamine receptor 1B [gi:112815] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol) | | AID | 625191 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 1B [gi:112815] | | PubMed | | | Data Table |  |
|
| 41 | [SID103735736] | Unspecified | IC50 | | DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) [AID625198, Type: other] | Alpha-1D adrenergic receptor [gi:1168244] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) | | AID | 625198 | | BioAssay type | other | | Target | Alpha-1D adrenergic receptor [gi:1168244] | | PubMed | | | Data Table |  |
|
| 42 | [SID103735736] | Unspecified | IC50 | | DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1) [AID625237, Type: other] | C-C chemokine receptor type 2 [gi:1168965] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1) | | AID | 625237 | | BioAssay type | other | | Target | C-C chemokine receptor type 2 [gi:1168965] | | PubMed | | | Data Table |  |
|
| 43 | [SID103735736] | Unspecified | | | Cytotoxicity against human Raji cells assessed as cell viability at 1000 mol ratio by trypan blue staining [AID348192, Type: Literature] | |   View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Unspecified | | BioAssay | Cytotoxicity against human Raji cells assessed as cell viability at 1000 mol ratio by trypan blue staining | | AID | 348192 | | BioAssay type | Literature | | Target | | | PubMed | 19131254 | | Data Table |  |
|
| 44 | [SID103735736] | Unspecified | | | Cytotoxicity against human Raji cells assessed as cell viability at 500 mol ratio by trypan blue staining [AID348193, Type: Literature] | |   View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Unspecified | | BioAssay | Cytotoxicity against human Raji cells assessed as cell viability at 500 mol ratio by trypan blue staining | | AID | 348193 | | BioAssay type | Literature | | Target | | | PubMed | 19131254 | | Data Table |  |
|
| 45 | [SID103735736] | Unspecified | | | Cytotoxicity against human Raji cells assessed as cell viability at 100 mol ratio by trypan blue staining [AID348194, Type: Literature] | |   View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Unspecified | | BioAssay | Cytotoxicity against human Raji cells assessed as cell viability at 100 mol ratio by trypan blue staining | | AID | 348194 | | BioAssay type | Literature | | Target | | | PubMed | 19131254 | | Data Table |  |
|
| 46 | [SID103735736] | Unspecified | | | Cytotoxicity against human Raji cells assessed as cell viability at 10 mol ratio by trypan blue staining [AID348195, Type: Literature] | |   View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Unspecified | | BioAssay | Cytotoxicity against human Raji cells assessed as cell viability at 10 mol ratio by trypan blue staining | | AID | 348195 | | BioAssay type | Literature | | Target | | | PubMed | 19131254 | | Data Table |  |
|
| 47 | [SID103735736] | Unspecified | | | Inhibition of DMBA-induced/TPA-promoted carcinogenesis in mouse assessed as reduction in skin papillomas bearing mouse at 85 nmol administered 1 hr before TPA treatment measured after 15 weeks [AID348197, Type: Literature] | |   View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Unspecified | | BioAssay | Inhibition of DMBA-induced/TPA-promoted carcinogenesis in mouse assessed as reduction in skin papillomas bearing mouse at 85 nmol administered 1 hr before TPA treatment measured after 15 weeks | | AID | 348197 | | BioAssay type | Literature | | Target | | | PubMed | 19131254 | | Data Table |  |
|
| 48 | [SID103735736] | Unspecified | | | Inhibition of DMBA-induced/TPA-promoted carcinogenesis in mouse assessed as reduction in skin papillomas bearing mouse at 85 nmol administered 1 hr before TPA treatment measured after 20 weeks [AID348198, Type: Literature] | |   View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Unspecified | | BioAssay | Inhibition of DMBA-induced/TPA-promoted carcinogenesis in mouse assessed as reduction in skin papillomas bearing mouse at 85 nmol administered 1 hr before TPA treatment measured after 20 weeks | | AID | 348198 | | BioAssay type | Literature | | Target | | | PubMed | 19131254 | | Data Table |  |
|
| 49 | [SID103735736] | Unspecified | | | Inhibition of DMBA-induced/TPA-promoted carcinogenesis in mouse assessed as number of skin papillomas per mouse at 85 nmol administered 1 hr before TPA treatment measured after 10 weeks [AID348199, Type: Literature] | |   View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Unspecified | | BioAssay | Inhibition of DMBA-induced/TPA-promoted carcinogenesis in mouse assessed as number of skin papillomas per mouse at 85 nmol administered 1 hr before TPA treatment measured after 10 weeks | | AID | 348199 | | BioAssay type | Literature | | Target | | | PubMed | 19131254 | | Data Table |  |
|
| 50 | [SID103735736] | Unspecified | | | Inhibition of DMBA-induced/TPA-promoted carcinogenesis in mouse assessed as number of skin papillomas per mouse at 85 nmol administered 1 hr before TPA treatment measured after 15 weeks [AID348200, Type: Literature] | |   View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 103735736 | | CID | 46878350 | | Outcome | Unspecified | | BioAssay | Inhibition of DMBA-induced/TPA-promoted carcinogenesis in mouse assessed as number of skin papillomas per mouse at 85 nmol administered 1 hr before TPA treatment measured after 15 weeks | | AID | 348200 | | BioAssay type | Literature | | Target | | | PubMed | 19131254 | | Data Table |  |
|